drugset / Trial / NCT01671111
Study for Transfusionally Iron Overloaded Children, Adolescents and Adults Using FBS0701 (SSP-004184)
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this extension study is to evaluate SSP-004184AQ in patients with transfusional iron overload and to provide data on long term safety and efficacy. SSP-004184AQ is an iron chelator under development for chronic daily oral administration to patients with transfusional iron overload
Timeline
- Start
- 2012-08-14
- Primary completion
- 2014-04-24
- Completion
- 2014-04-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SPD602 | Unknown | 8 mg/kg | Oral |
| Subject | SPD602 | Unknown | 75 mg/kg | Oral |